Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Argatroban recalled?

Not under an active recall. Argatroban was recalled 4 times in the past — all now closed. Most recent: Aug 28, 2018.

Most common reason: Impurity / degradation (2 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Argatroban. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Argatroban recalls on record

none so far in 2026; 4 on record, newest first
Class III · Low risk

Argatroban Injection

Failed Impurities/Degradation Specifications; Out of specification stability testing results at the 18 month time point

Terminated Impurity / degradation Pfizer Inc. D-1184-2018
Class III · Low risk

Argatroban Injection

Failed Impurities/Degradation Specifications; out of specification result for denitroquinoline-related impurity during three month time point

Terminated Impurity / degradation Hospira Inc., A Pfizer Company NDC 0409-1140-01 D-0980-2017
Class I · High risk

Argatroban Injection 50 mg per 50ml

A complaint was received from a hospital pharmacy on 11/10/11 for crystalline particulates in a single vial from Lot V10194. Additional small visible particles consisting of fibers were identified.

Terminated Particulate / foreign matter Eagle Pharmaceuticals Inc. NDC 42367-203-07 D-1429-2012